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Main message
	The UK is a top 5 contributor to global neurosurgical research output.
	There are structured and unstructured academic neurosurgical training routes. 
	Funding is a bottleneck for neurosurgeons pursuing academia. 
	Academic neurosurgical bodies in the UK foster subspecialty research.
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Abstract
Academic neurosurgery encompasses basic science and clinical research efforts to better understand and treat diseases of relevance to neurosurgical practice, with the overall aim of improving treatment and outcome for patients. In this article, we provide an overview of the current and future directions of British academic neurosurgery. Training pathways are considered together with personal accounts of experiences of structured integrated clinical academic training (ICAT) and unstructured academic training. Life as an academic consultant is also described. Funding is explored, for the specialty as a whole and at the individual level. UK academic neurosurgical organisations are highlighted. Finally, the UK’s international standing is considered. 
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Background and history
Academic neurosurgery encompasses basic science and clinical research efforts to better understand and treat diseases of relevance to neurosurgical practice. Academic neurosurgery is practiced by academic neurosurgeons, who can be of at least three types: translational basic scientists – undertaking predominantly translational science research; clinical academics – undertaking predominantly clinical research; and research active clinicians – whose time is divided in favour of clinical commitments to regular research efforts. The ultimate aim of academic neurosurgery is to improve patient outcome and lead to a better understanding of disease processes to guide novel therapies. 

The development of modern neurosurgery in the UK has been underpinned by academic enquiry. For example, in Glasgow, William Macewen introduced Lister’s aseptic techniques to revolutionise the treatment of brain abscesses.1 In London, Victor Horsley carried out experiments in brain localisation, acting as the Professor Superintendent of the Brown Institution, the University of London’s animal experimental base.2 In Oxford, the relocated Hugh Cairns published extensively on the need for helmets for motorcyclists and the repair of cranial defects with acrylic or titanium.3

Today, research forms an integral part of neurosurgical training and practice. ADDIN EN.CITE 4, 5 The aim of this article is to present an overview of the current and future directions of British academic neurosurgery.

Training
Clinical and academic training requires dedicated time and commitment. Table 1 shows a comparison between clinical and academic pathways. There are two main routes for neurosurgical trainees with an interest in academia, which are not mutually exclusive: 
	Structured academic training: this is via the Integrated Clinical Academic Training (ICAT) scheme. It includes defined short-term posts with allocated clinical and academic time. Structured academic neurosurgical training is being offered in an increasing number of regions.
o	Postgraduate academic training in England proceeds serially through the academic foundation programme (AFP), academic clinical fellowship (ACF), higher degree (PhD/MD), and academic clinical lectureship (ACL). Each of these stages represents a potential bottleneck in pursuit of academic practice. Entry is competitive, based on a formal application and interview. Furthermore, at the ACF/ACL stages, unless already appointed on a clinical training post, applicants must also apply to the national selection centre and be deemed eligible at national clinical interviews. There are currently only 27 neurosurgical trainees appointed to an ACF/ACL post. This compares to 264 neurosurgical trainees appointed to conventional clinical training posts (unpublished data from the Joint Committee on Surgical Training, JCST). 
o	In Wales, academic trainees are appointed to the Wales Clinical Academic Trainee (WCAT) Program. It currently differs from the English programme in that academic training is also run-through, subject to satisfactory academic performance, and clinical salaries are maintained during their higher degree (usually a PhD). National Selection or WCAT Trainees can also be appointed to the Wellcome Trust funded GW4 Clinical Academic Training programme across Cardiff, Bristol, Bath and Exeter Universities. Table 2 shows the geographical distribution of ACF/ACL trainees based in England and Wales.
o	In Scotland, academic training differs in that graduates must firstly gain a national training number through conventional specialty application systems. They can then apply for run-through pre-doctoral academic schemes (e.g. Edinburgh Clinical Academic Track (ECAT) Lectureship, Scottish Clinical Research Excellence Development Scheme (SCREDS) Lectureship). 
o	Beyond these stages, senior academic trainees and those that have completed training can apply for personal award schemes such as the NIHR Clinician Scientist scheme. This offers up to 5 years funding towards a programme of research. 
	Unstructured academic training: this includes ad-hoc academic experience obtained through research projects leading to MDs or PhDs, without necessarily having the same opportunity for dedicated time away from clinical work or access to structured mentorship programmes.

Case studies to highlight these are presented in Table 3. Importantly, trainees engaging in academia must meet the same clinical competencies as other trainees to gain their Certification of Completion of Training (CCT). A higher degree is a key component of academia and on average, 30 trainees per year take time out of their training programme to pursue a higher degree (unpublished data from the JCST). Neurosurgery is amongst the specialties that includes academia in its curriculum and trainees can therefore count up to 12 months of out of programme research (OOPR) towards their training. Trainees undertaking a higher degree in the mid to end stages of their clinical training can also continue to participate on the registrar on-call rota. This provides a financial supplement and opportunity to maintain clinical skills, but may reduce academic time.

In future, the number of structured academic posts is likely to increase and run-through academic training may also eventually be offered in England.

Academic consultants and professors
Academic interests continue for many neurosurgeons following completion of training. In general, neurosurgeon translational basic scientists and clinical academics hold university positions with honorary consultant contracts, whilst research active clinical neurosurgeons are primarily employed by the NHS in purely clinical roles and may or may not hold honorary university contracts. The “craft” nature of the neurosurgical discipline also means that, regardless of academic category, academic neurosurgeons must dedicate a substantial amount of their time to clinical practice. 

The Society of British Neurological Surgeons (SBNS) holds a database of consultant members with registered research interests. There are currently 13 practicing Professors of Neurosurgery in the UK, including 4 honorary professors. Of the remaining consultants in the database, job plans are as follows: standalone full-time NHS appointment (9, 24%); full-time NHS appointment with honorary university affiliation (20, 54%); and full-time university academic appointment with honorary consultant contract (8, 22%). Most academic consultants hold post-graduate research degrees, namely MDs (26%) or PhDs (44%). By reviewing their output from the last 5 years listed on MEDLINE, almost half (45%) have laboratory science interests, although research output is predominantly clinical.

Neurosurgeon translational basic scientists and clinical academics have to deliver both patient care and research. This requires funding from both internal and external streams, usually only available on a competitive basis. Academic output is also monitored in terms of the Research Excellence Framework (REF), which is not required for NHS clinically active neurosurgeons.

Funding
Given the small size of the specialty, neurosurgery has been successful in securing income from major funders (see table 4 for data on NIHR Personal Awards Programmes). However, research funding remains a bottleneck for neurosurgeons pursuing academia. This bottleneck is also faced by those on NIHR sponsored ACF and ACL programmes, which come with financial support to cover conference attendance but not research costs or bench fees.

Funders with an interest in neurosurgical themes are advertised on the SBNS website, though this is by no means exhaustive. Most available funding streams are for PhD studentships. In terms of national research councils, the MRC (UK) offers support to surgical trainees in clinical posts in the form of Clinical Research Training Fellowships whilst the Wellcome Trust offers PhD Fellowships for Clinicians via their specific university centres. In cases where the project relates to specific disciplines such as neuro-oncology, charities such as Cancer Research UK and Epilepsy Research UK offer fellowships. The RCS England offers one year surgical research fellowships including salary (30 awarded in 2016-17). A number of PhD studentships are also funded in collaboration with industry, for example in projects investigating a specific device or product. 

Postdoctoral fellows face similarly tough hurdles to fund ongoing research. The options include applying for personal grants as part of Clinician Scientist Fellowships (NIHR or MRC affiliated) or funding as principal or co-principal investigators on project grants or studies. Pump priming grants are available from the Surgical Royal Colleges for the purposes of supporting small projects. For trainees wishing to secure University academic positions, Clinician Scientist fellowships are almost a requisite, as is a track record of significant grant income and evidence of developing an independent research programme of work.

In future, as academic neurosurgery grows in the UK, one potential solution to increasing funded programmes is jointly funded posts by a research body or council and a charity, as are increasingly being offered in other specialties.

Academic neurosurgical bodies in the UK
The Academic Committee of the Society of British Neurological Surgeons (SBNS-AC) has overall strategic responsibility of academic neurosurgical matters in the UK. The committee consists of academic neurosurgeons, representatives from the various neurosurgical subspecialty interest groups, trainees and SBNS council. Since 2010, a dedicated research manager has been employed to coordinate the development of neurosurgical research and trials in the UK. Additionally, the academic committee is responsible for organising an annual two-day meeting focussing on neurosurgical research, known as British Neurosurgical Research Group meeting. The meeting is hosted by various neurosurgical units in the UK and provides a forum for discussion of pilot research findings and pitching of new research ideas. 

The various neurosurgical subspecialty interest groups (cerebrospinal fluid, functional, oncology, paediatrics, trauma, vascular, skull base, spine) are actively engaged in research either by initiating or supporting multi-centre research activities as well as investigating basic mechanisms underlying the relevant disease states. The scope of the subspecialty interest groups extends beyond academia, for example, the British Neurovascular Group has setup a UK and Ireland subarachnoid haemorrhage database with almost 90,000 cases registered to date. 

The trainee-led British Neurosurgical Trainee Research Collaborative (BNTRC) was formed in 2012, with support from the academic committee of the SBNS. The BNTRC has successfully facilitated a number of multi-centre studies and been instrumental in the setup of two ongoing randomised controlled trials, RESCUE-ASDH and Dex-CSDH (see Table 6). The model used by the BNTRC includes peer review of national study proposals by relevant members of the SBNS-AC, as well as internal committee review. Two examples of completed BNTRC initiatives include the national external ventricular drain study and the national chronic subdural haematoma study, both of which have published results. ADDIN EN.CITE 6, 7 Recently, the BNTRC has also collaborated with the UK’s Neurology and Neurosurgery Interest Group (NANSIG), a network of medical students and junior doctors, to successfully complete a national prospective observational study on cauda equina syndrome (Evaluation of National Treatment and Investigation of Cauda Equina Syndrome, ENTICE). The BNTRC committee recently published a paper outlining the progress made in the first 5 years and vision for the future including the potential for global collaboration. ADDIN EN.CITE 8 

The future direction of these organisations will probably be towards international collaboration as done so by other surgical specialties. For example, GlobalSurg was setup by general surgeons and now boasts a member-base of over 5000 surgeons worldwide. The organisation has successfully completed observational studies on an international level.9 Within neurosurgery, the NIHR Global Health Research Group on Neurotrauma has been setup and aims to foster collaborative traumatic brain injury research with developing countries and fund UK-based posts and international PhD students. There is also an argument for developing a group of neurosurgeon translational scientists to foster progress in basic science research in neurosurgery, as translational medicine first requires something to translate into clinical practice.

International standing
The UK is amongst the top 5 producers of neurosurgical publications globally. It has similar standing when considering the mean journal impact factor of publications.10 This is particularly impressive considering that the UK has a much lower neurosurgeon to population ratio (0.55 per 100,000 population, based on the number of full SBNS members) compared to the other top 5 producers such as the United States (1.613 per 100,000 population) and Japan (5.895 per 100,000 population).11 The sparsity of neurosurgical training and consultant posts probably helps to sustain the national academic output through healthy competition. Nevertheless, there is still marked discrepancy between neurosurgical units in UK and USA when considering the mean H-index, which is almost half in the UK what it is in the USA. ADDIN EN.CITE 5, 12 

The UK is also a top 5 contributor to neurosurgical RCTs.10 There have been a number of international multi-centre trials with a UK based neurosurgical principal (Table 5). ADDIN EN.CITE 13-19 Most recently, the RESCUEicp trial published its results of decompressive craniectomy versus medical management of raised intracranial pressure in the setting of trauma, that is refractory to two tiers of medical therapy. ADDIN EN.CITE 14 Other active trials with a UK-based neurosurgical PI are shown in Table 6. The number of active trials is likely to increase in future, aided by projects such as The Royal College of Surgeons’ Surgical Trials Initiative.20 Specialty leads (PJAH for neurosurgery) are appointed under this initiative to foster trial development within their specialty through 7 regional surgical trials centres. 

In the context of Europe, research in the UK may be negatively affected by the results of the EU referendum (“Brexit”). This is in at least three ways: reputation – there may be a reluctance from Europe to include UK sites in multi-centre studies; pharma relocation – companies may base their workings offshore and preferentially back and fund European PIs; employment – there are already reports of recruitment difficulties in relation to UK based positions, and researchers may choose to base their operations elsewhere.21 

Conclusion
Academic neurosurgery has a rich history in the UK, which remains a top 5 contributor to global research output based on publication count and the number of active randomised trials. There are an increasing number of opportunities for trainees and consultants to be involved with academia. Structured academic training with allocated research time has a number of benefits compared to ad-hoc research and may well become the norm with time. At every level, academic engagement provides the opportunity to directly improve patients’ care, mental stimulation, the potential for collaboration and continued professional development. There are several challenges ahead for academic neurosurgery in the UK including how to increase access to funding, maintaining momentum and taking steps towards global collaboration.
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Clinical training 	Integrated Clinical Academic Training 	Academic Training 
Medical School	MB/PhD programmes	Undergraduate degree(e.g. Bsc)
Foundation Programme	Academic Foundation Programme (AFP): up to 4 months of research over a 2-year period	Pre-doctoral research activity (e.g. MSc)
Specialty Training (SHO)	Academic Clinical Fellowship (ACF): up to 9 months of research over a 3-year period Wales Clinical Academic Training (WCAT) postsRun through Academic Training ST1-ST8 including PhD	Doctoral training (e.g. PhD)
Specialty Training (Registrar)	Academic Clinical Lectureship (ACL): up to 2-years of research over a 4-year periodWales Clinical Academic Training (WCAT) postsRun through Academic Training ST1-ST8 including PhD and subsequent Clinical Lectureship	Post-doctoral Training
Consultant 	Clinician Scientist (senior trainees also eligible for this award)	Principal investigator
 Table 1. Clinical, integrated and academic training pathways in the UK. 

Table 2. Geographical distribution of currently appointed Academic Clinical Fellows (ACFs) and Academic Clinical Lecturers (ACLs) in Neurosurgery in England and Wales. Source: NIHR Trainees Coordinating Centre and local data from WPG.


Health Education England Region	ACF	ACL
East of England	2	1
North Central and East London	1	0
North West	2	2
North West London	1	1
South London	0	1
South West	1	0
Thames Valley	1	1
West Midlands	0	1
Wales		
Cardiff	2	1
Grand Total	10	8
 

Table 3. Experience of academic neurosurgery: a series of accounts by trainees and consultants.  

Academic Foundation Programme (AFP)Mueez Waqar Salford Royal Hospital, Manchester	The AFP is a 2-year appointment with dedicated academic time. The nature of the academic time varies by deanery and can be in blocks or days per week. In my deanery, I was given one 4-month academic block in foundation year 2, without any on call commitments. I was very well supported from the start and had complete flexibility to pursue any research area I wanted. As I had an interest in neurosurgery, I chose to pursue a pituitary based project at my base hospital. I thought that the research I did during my academic block this was a step up from research I had done as a student as I was expected to refine a research question and develop study methodology. Data collection and analysis was again more independent, but my supervisor was always at hand to help where needed. My study was eventually presented and published. At the end of the year, all of the AFPs presented their projects at a regional event, which I thought was a nice touch. I really enjoyed my AFP and it sparked an interest in an academic career. However, to do well in the programme, you have to overcome reduced clinical exposure at such an early stage, which is easily achieved through locum shifts and clinic/theatre visits. 
NIHRAcademic Clinical Fellowship (ACF)Benjamin M DaviesCambridge University Hospitals NHS Foundation Trust, Cambridge	The ACF is a 3-year appointment, which comes with an allocation of 25% protected academic time. On-call commitments continue but you are removed from routine day-to-day practice. How and when the academic allocation is taken will vary on a centre and individual basis. I was awarded the ACF at ST1 and have chosen to take my academic time at the end of my appointment. The attraction of this arrangement for me was to balance sufficient clinical progression to support my entry onto the junior registrar rota, whilst offering the opportunity of running into a PhD or alike. Alternative options were an allocation each year or each week, but this will need to align with the practicalities of the department also.In Cambridge, I am now part of Dr Mark Kotter’s research group, leading his clinical research programme on Cervical Myelopathy. I arrived in Cambridge without any special research topic of interest but found the combination of prevalence and significant unmet need in myelopathy an attractive and worthwhile focus. Over the last 3 years we have established the first international charity for myelopathy, commenced patient research priority and core outcome initiatives, identified delays in diagnosis, including potential influences such as deficiencies in medical training, clinical examination, clinical assessments and the qualitative reporting of MRI imaging. We are developing a new pocket assessment for myelopathy and building towards the first regenerative medicine trial for myelopathy (RECEDE-Myelopathy), for which I am a trainee PI. An ACF appointment is clearly not the only route into academic neurosurgery, but it is certainly a very useful opportunity. The programme has afforded me not just protected research time, but through the accompanying programmes provided by the University and NIHR, great academic training and opportunities to network. I have found that balancing clinical training with academia and a personal life is difficult, and no doubt that problem will remain.  However, I have always enjoyed the research foil to clinical practice and I see it as something which can challenge me throughout my career.
NIHRAcademic Clinical Lectureship (ACL)Kenny YuSalford Royal Hospital, Manchester	The ACL scheme is typically a 4-year appointment with 50% research time. It is usually awarded to trainees within the final 2 years of their training and is seen as a bridging scheme to assist those who have completed a higher research degree to complete further post-doctoral research to strengthen their application for an intermediate fellowship or clinician scientist fellowship at the end of training. Research time can be taken up to a maximum of 2 years, though the full research time does not have to be taken. The scheme technically ends at the point of CCT - the date of which can be negotiated with each trainee’s host deanery. I entered the ACL scheme at ST7 level in Manchester. My experience in Manchester has been that my training and research needs have been well supported. In my first year, I was able to take my full 50% protected time (6 months) for a research fellowship at The Hospital for Sick Children and St. Michael’s Hospital in Toronto, Canada, where I was able to gain post-doctoral research experience. In my second year, I was able to leverage this experience to successfully apply for a grant which I will now use to generate pilot data. My typical week is currently split into 2.5-3 days of clinical activity, which are typically elective theatre sessions for two days and a clinic session, MDT or theatre list for the remainder. On call commitments are halved. My research days are spent at the university where I am part of a wider Neuro-inflammation/Neuro-oncology group where I set up experiments, attend lab meetings and catch up with papers and other administrative duties. My experience of the ACL scheme in Manchester has been extremely positive, but the success of the scheme is largely down to the level of support provided by the host clinical department.
NIHRClinician Scientist AwardMark RN KotterCambridge University Hospitals NHS Foundation Trust, Cambridge	The NIHR Clinician Scientist Award is awarded for a period up to 5 years to postdoctoral senior trainees or consultants. I am supported by this award in my capacity as a consultant neurosurgeon with a sub-specialist interest in complex spine surgery. In every given week, there will be sessions scheduled for theatre, outpatient appointments, and other clinical activities. I also participate in the complex spine on-call rota. The remainder of the week is free for research. Our focus is regenerative medicine, stem cells, and spinal cord injury. As the lead for academic spine, I am tasked with building a translational research program for spinal pathologies in Cambridge. I am particularly interested in cervical myelopathy CSM, the most common form of spinal cord dysfunction of adulthood. Supported by the NIHR, we are currently preparing RECEDE (REgeneration in CErvical DEgenerative) Myelopathy, the first regenerative medicine trial in CSM.I lead a basic science research lab that investigates mechanisms of regeneration of the Central Nervous System, and which provides the basis of our clinical research. The need for better (human) models led us to develop a technology that has simplified the generation of human cells using a novel approach termed "direct cell reprogramming". This provides a scalable platform for studying neurological diseases and has opened exciting opportunities for collaboration. I enjoy the independence and the great variety of my work. Three points are fundamental: 1) patients always come first; 2) find synergies between the different aspects of your work to keep focussed, and 3) bring together the right people, support them and build strong teams.
Traditional PhD via non ICAT routeRasheed ZakariaWalton Centre NHS Foundation Trust, Liverpool	Trainees can undertake higher degrees at any point in their training. Usually, the choice is between a funded project that is “ready to go” and arguably, the longer route - obtaining a PhD fellowship grant based on an idea. I pursued the 2nd of these options with a project developed with local support around investigating local invasion and outcomes in brain metastases. As a trainee in Liverpool, I initially received funding from my trust through research capacity funding in order to cover my salary for 12 months and allow me to gather pilot data for a bigger research proposal. I continued doing locum on calls to supplement my income and maintain clinical skills during this period. I received further support from the Royal College of Surgeons of England to help with salary and consumable costs via their one year Research Fellowship Programme and finally was able to compete for and win a national MRC (UK) Clinical Research Training Fellowship to fully fund the completion of my PhD, including fees and other on-costs. My experience was less conventional and only possible with excellent support and enthusiasm from my clinical and research mentors. Overall this patchwork of funding was slightly stressful at times because I was constantly looking for the next award but it meant that I had the experience of having to write multiple applications and focus my research goals and experimental plan very tightly. Finally, working on brain metastases has been very fruitful as it is something of a neglected area despite being common and important. As a result, I have been able to develop strong international collaborations in this field and this has stood me in good stead for post-doctoral projects which I am now developing.


Table 4. Funding from NIHR Personal Award Programmes for surgical specialties and neurology (2006-present). This table shows the total amount awarded to various specialties including neurosurgery. This is the sum of NIHR Professorships, NIHR Clinician Scientist Awards, NIHR Fellowships and NIHR Clinical Trials Fellowships. Note that subset data for vascular surgery was not available. Source: NIHR Trainees Coordinating Centre. 


Specialty	Total from NIHR Personal Award Programmes (£) 
General surgery	7,741,095
Neurology	7,576,545
Ophthalmology	5,360,189
Neurosurgery	4,786,852
Paediatric surgery	2,149,461
Otolaryngology	1,909,177
Trauma and orthopaedics	1,196,700
Plastic surgery	1,062,376
Urology	642,202
Cardiothoracic surgery	341,995
Oral Maxillofacial Surgery	304,239






Table 5. Completed phase III trials with a UK-based neurosurgical PI. ADDIN EN.CITE 13-19, 22
 
Subspecialty	Name 	Inclusion criteria (simplified)	Randomised groups	Primary outcome and result
Trauma	Surgical Trial in Traumatic intraCerebral Haemorrhage(STITCH)	Adults (≥14 years)Traumatic intracerebral haematoma measuring ≥10mlNo subdural or extradural haematoma requiring surgery Ictus ≤48 hoursClinical equipoise of surgical vs. non-surgical management No severe physical/mental comorbidity	Early surgery ≤12h Initial conservative management	Extended Glasgow Outcome Scale at 6 monthsRecruitment stopped early but surgery group had favourable outcome 
	Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma	Age ≥18 yearsSymptomatic chronic subdural haematoma (bilateral subdurals treated as single case receiving same treatment on both sides)No ipsilateral shunt in past 6 monthsSuitable for burr-hole evacuationIntra-operatively, drain insertion deemed safe	Drain: soft silicone subdural drain, subdural space filled with saline during closure, drain kept in dependent position for 48h No drain: subdural space filled with saline during closure	Rate of surgically treated symptomatic recurrence within 6 monthsRate significantly lower in drain group
	Randomised Evaluation of Surgery with Craniectomy for Uncontrollable Elevation of Intracranial Pressure (RESCUEicp) 	Adolescents and adults (10-65 years)Survivable traumatic brain injury with abnormal CT brainNo previous craniectomyIntracranial pressure ≥25 mmHg for 1-12 hours refractory to stage 1 and 2 measuresNo bleeding diathesis	Medical treatment and hemi- or bifrontal craniectomy within 4-6 hoursMedical treatment +/- barbiturates	Extended Glasgow Outcome Scale at 6 months: surgery group had lower mortality but higher rate of severe disability including vegetative state
Vascular	BRitish Aneurysm Nimodipine Trial (BRANT)	Adults (≥18 years, non-pregnant)Aneurysmal subarachnoid haemorrhagePresentation ≤92 hours of Ictus No major renal, hepatic, pulmonary or cardiac disease (including myocardial infarction ≤6 months)No subarachnoid haemorrhage in past week producing coma	21-day course of enteral 60mg nimodipine 4-hourly 21-day course of placebo  	Rate of cerebral infarction at 3 months: significantly lower in nimodipine group
	International Subrachnoid Aneurysm Trial (ISAT) 	Aneurysmal subarachnoid haemorrhageIctus ≤28 daysClinical state justified treatment Aneurysm amenable to either endovascular or open surgical treatment and equipoise in which to use	Endovascular treatment (coiling)Open surgery (mostly clipping)	Modified Rankin Score at 12 months: endovascular group had lower rates of mortality and dependence
	Surgical Trial in Intracerebral Haemorrhage (STICH) 	Spontaneous supratentorial intracerebral haematoma ≥2cm, not extending to brainstem GCS ≥5Ictus ≤72 hoursClinical uncertainty about surgical vs. non-surgical managementNo severe physical/mental comorbidity 	Early surgery ≤24h Initial conservative management	Glasgow Outcome Score at 6 months: no significant difference
	Surgical Trial in Intracerebral Haemorrhage II(STICH II)	Spontaneous supratentorial lobar intracerebral haematoma, ≤1cm from cortical surface, measuring 10-100mlNot involving basal ganglia, thalamus or brainstem No intraventricular haemorrhageIctus ≤48 hoursGCS motor score ≥5 and eye score ≥2No severe physical/mental comorbidity 	Early surgery ≤12h Initial conservative management	Extended Glasgow Outcome Scale at 6 months: no significant difference
	SimvasTatin in Aneurysmal SubArachnoid Haemorrhage (STASH) 	Adults (18-65 years, non-pregnant) Aneurysmal subarachnoid haemorrhage with reasonable prospect of survival Presentation ≤96 hours from ictusFully independent baseline and no renal/hepatic impairment or drug misuseNot taking statin, anticoagulant or contraindicated medication 	21-day course of Simvastatin 40mg 21-day course of Placebo 	Modified Rankin Scale at 6 months: no significant difference



Table 6. Ongoing phase III clinical trials with a UK-based neurosurgical PI. *PI is an interventional vascular neuoradiologist, but given its relevance, the trial was included in this list.
Subspecialty	Name 	Inclusion criteria (simplified)	Randomised groups	Primary outcome
Trauma	Randomised Evaluation of Surgery with Craniectomy for patients Undergoing Evacuation of Acute Subdural Haematoma(RESCUE-ASDH)	Adults (>16 years)Acute traumatic subdural haematomaTreatment with surgery	Bone flap put backBone flap left off	Extended Glasgow Outcome Scale at 12 months
	A randomised, double blind, placebo-controlled trial of a two-week course of dexamethasone for adult patients with a symptomatic Chronic Subdural Haematoma (Dex-CSDH)	Adults (≥16 years)Chronic subdural haematoma causing symptomsNo contraindications to use of steroids	2-week course of placebo2-week tapered course of dexamethasone	Modified Rankin scale at 6 months
Oncology	Radiation versus Observation following surgical resection of Atypical Meningioma(ROAM)	Adults (≥16 years)WHO grade II meningiomas in all locations except optic nerve sheathSimpson grade 1-3 resectionSufficient performance status (ECOG 0-2) and willingness to commence radiotherapy within 12 weeks	No postoperative radiotherapyPostoperative radiotherapy	Radiological progression-free survival at 0.5, 1 and 5-years post-surgery
Paediatrics and hydrocephalus	British Antibiotic and Silver Impregnated Catheters for ventriculoperitoneal Shunts(BASICS)	Adults and childrenHydrocephalus of any aetiologyPrimary treatment with a ventriculoperitoneal shunt (VPS)Clear CSF sample at the time of shunt insertion	Non-impregnated VPSSilverline (Silver impregnated) VPSBactiseal (antibiotic impregnated) VPS	Early shunt infection rate (within 6 months)
Spine	NErve Rootblock VErsus Surgery(NERVES)	Adults (16-65 years)Sciatica secondary to lumbar disc herniation for 6 weeks to 12 months No serious neurological deficitFailed conservative treatment for 6 weeks	Epidural steroid injectionMiscrodiscectomy	Oswestry Disability Questionnaire at 3 months
	FORaminotomy Versus Anterior Discectomy (FORVAD)	Adults (≥18 years)Unilateral or bilateral cervical brachialgia secondary to nerve root compression for at least 6 weeksSingle or 2-level nerve entrapmentPosterolateral disc and/or foraminal narrowingFailed conservative management	Posterior Cervical Foraminotomy (PCF)Anterior Cervical Discectomy (ACD)	Neck Disability Index at 12 months
Vascular	Treatment Of Poor-grade SubArachnoid haemorrhage Trial 2(TOPSAT 2)*	Adults (18-80 years)WFNS grade IV or V aneurysmal subarachnoid haemorrhageDoes not meet criteria for brainstem deathConventional saccular aneurysm 	Treatment of aneurysm within 24 hours of ictusTreatment of aneurysm after neurological improvement to WFNS grade 1-3	Modified Rankin Score at 12 months
	SubCutaneous InterLeukin-1 receptor antagonist in SubArachnoid Haemorrhage (SCIL SAH)	Adults (≥18 years, non-pregnant) Aneurysmal subarachnoid haemorrhageNo significant concurrent illness 	Treatment with 72 hours of ictus: Interleukin receptor antagonist - twice daily for 21 days or dischargePlacebo 	Modified Rankin Score at 6 months
Epilepsy	Fluoxetine in Learning and Memory in Epilepsy (FLAME)	Adults (18-70 years)Mesial temporal lobe epilepsy with hippocampal sclerosisNot depressed or anxious as assessed by the Hospital Anxiety and Depression ScaleNot on concurrent antidepressants	Fluoxetine Placebo	Spatial learning
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